Global Insulin API Supply, Demand and Key Producers, 2024-2030

Global Insulin API Supply, Demand and Key Producers, 2024-2030

Page: 131

Published Date: 18 Feb 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Insulin API market size is expected to reach $ 2175.5 million by 2030, rising at a market growth of 2.8% CAGR during the forecast period (2024-2030).

The major players in global Insulin API market include Novo Nordisk, Sanofi-Aventis, etc. The top 2 players occupy over 65% shares of the global market. North America and Europe are main markets, they occupy about 70% of the global market. Insulin Analogue is the main market, and occupies about 90% of the global market. Long-Acting is the main type, with a share over 40%.

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.

In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin. Basing on the trend of China and Chinese insulin industry, this report researches the market of human insulin and insulin analogue in China.

In this report, the statistics of insulin industry is based on Insulin API, the physical features of insulin API is Freeze-dried powder. The weight unite of insulin API weight is Kg in this report.

This report studies the global Insulin API production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Insulin API, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Insulin API that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Insulin API total production and demand, 2019-2030, (K Units)
Global Insulin API total production value, 2019-2030, (USD Million)
Global Insulin API production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Insulin API consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Insulin API domestic production, consumption, key domestic manufacturers and share
Global Insulin API production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Insulin API production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Insulin API production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Insulin API market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Sanofi-Aventis, Eli Lilly, Tonghua Dongbao, Ganlee, United Laboratory, Biocon, Amphastar and Wockhardt, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Insulin API market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Insulin API Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Insulin API Market, Segmentation by Type
Regular Human Insulin
Insulin Analogue

Global Insulin API Market, Segmentation by Application
Fast-Acting
Premix
Long-Acting

Companies Profiled:
Novo Nordisk
Sanofi-Aventis
Eli Lilly
Tonghua Dongbao
Ganlee
United Laboratory
Biocon
Amphastar
Wockhardt
Julphar Diabetes
Torrent Pharma

Key Questions Answered
1. How big is the global Insulin API market?
2. What is the demand of the global Insulin API market?
3. What is the year over year growth of the global Insulin API market?
4. What is the production and production value of the global Insulin API market?
5. Who are the key producers in the global Insulin API market?
btl

Table of Contents

1 Supply Summary
1.1 Insulin API Introduction
1.2 World Insulin API Supply & Forecast
1.2.1 World Insulin API Production Value (2019 & 2023 & 2030)
1.2.2 World Insulin API Production (2019-2030)
1.2.3 World Insulin API Pricing Trends (2019-2030)
1.3 World Insulin API Production by Region (Based on Production Site)
1.3.1 World Insulin API Production Value by Region (2019-2030)
1.3.2 World Insulin API Production by Region (2019-2030)
1.3.3 World Insulin API Average Price by Region (2019-2030)
1.3.4 North America Insulin API Production (2019-2030)
1.3.5 Europe Insulin API Production (2019-2030)
1.3.6 China Insulin API Production (2019-2030)
1.3.7 Japan Insulin API Production (2019-2030)
1.3.8 Mid East & Africa Insulin API Production (2019-2030)
1.3.9 India Insulin API Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Insulin API Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Insulin API Major Market Trends

2 Demand Summary
2.1 World Insulin API Demand (2019-2030)
2.2 World Insulin API Consumption by Region
2.2.1 World Insulin API Consumption by Region (2019-2024)
2.2.2 World Insulin API Consumption Forecast by Region (2025-2030)
2.3 United States Insulin API Consumption (2019-2030)
2.4 China Insulin API Consumption (2019-2030)
2.5 Europe Insulin API Consumption (2019-2030)
2.6 Japan Insulin API Consumption (2019-2030)
2.7 South Korea Insulin API Consumption (2019-2030)
2.8 ASEAN Insulin API Consumption (2019-2030)
2.9 India Insulin API Consumption (2019-2030)

3 World Insulin API Manufacturers Competitive Analysis
3.1 World Insulin API Production Value by Manufacturer (2019-2024)
3.2 World Insulin API Production by Manufacturer (2019-2024)
3.3 World Insulin API Average Price by Manufacturer (2019-2024)
3.4 Insulin API Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Insulin API Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Insulin API in 2023
3.5.3 Global Concentration Ratios (CR8) for Insulin API in 2023
3.6 Insulin API Market: Overall Company Footprint Analysis
3.6.1 Insulin API Market: Region Footprint
3.6.2 Insulin API Market: Company Product Type Footprint
3.6.3 Insulin API Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Insulin API Production Value Comparison
4.1.1 United States VS China: Insulin API Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Insulin API Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Insulin API Production Comparison
4.2.1 United States VS China: Insulin API Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Insulin API Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Insulin API Consumption Comparison
4.3.1 United States VS China: Insulin API Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Insulin API Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Insulin API Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Insulin API Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Insulin API Production Value (2019-2024)
4.4.3 United States Based Manufacturers Insulin API Production (2019-2024)
4.5 China Based Insulin API Manufacturers and Market Share
4.5.1 China Based Insulin API Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Insulin API Production Value (2019-2024)
4.5.3 China Based Manufacturers Insulin API Production (2019-2024)
4.6 Rest of World Based Insulin API Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Insulin API Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Insulin API Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Insulin API Production (2019-2024)

5 Market Analysis by Type
5.1 World Insulin API Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Regular Human Insulin
5.2.2 Insulin Analogue
5.3 Market Segment by Type
5.3.1 World Insulin API Production by Type (2019-2030)
5.3.2 World Insulin API Production Value by Type (2019-2030)
5.3.3 World Insulin API Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World Insulin API Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Fast-Acting
6.2.2 Premix
6.2.3 Long-Acting
6.3 Market Segment by Application
6.3.1 World Insulin API Production by Application (2019-2030)
6.3.2 World Insulin API Production Value by Application (2019-2030)
6.3.3 World Insulin API Average Price by Application (2019-2030)

7 Company Profiles
7.1 Novo Nordisk
7.1.1 Novo Nordisk Details
7.1.2 Novo Nordisk Major Business
7.1.3 Novo Nordisk Insulin API Product and Services
7.1.4 Novo Nordisk Insulin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Novo Nordisk Recent Developments/Updates
7.1.6 Novo Nordisk Competitive Strengths & Weaknesses
7.2 Sanofi-Aventis
7.2.1 Sanofi-Aventis Details
7.2.2 Sanofi-Aventis Major Business
7.2.3 Sanofi-Aventis Insulin API Product and Services
7.2.4 Sanofi-Aventis Insulin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Sanofi-Aventis Recent Developments/Updates
7.2.6 Sanofi-Aventis Competitive Strengths & Weaknesses
7.3 Eli Lilly
7.3.1 Eli Lilly Details
7.3.2 Eli Lilly Major Business
7.3.3 Eli Lilly Insulin API Product and Services
7.3.4 Eli Lilly Insulin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Eli Lilly Recent Developments/Updates
7.3.6 Eli Lilly Competitive Strengths & Weaknesses
7.4 Tonghua Dongbao
7.4.1 Tonghua Dongbao Details
7.4.2 Tonghua Dongbao Major Business
7.4.3 Tonghua Dongbao Insulin API Product and Services
7.4.4 Tonghua Dongbao Insulin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Tonghua Dongbao Recent Developments/Updates
7.4.6 Tonghua Dongbao Competitive Strengths & Weaknesses
7.5 Ganlee
7.5.1 Ganlee Details
7.5.2 Ganlee Major Business
7.5.3 Ganlee Insulin API Product and Services
7.5.4 Ganlee Insulin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Ganlee Recent Developments/Updates
7.5.6 Ganlee Competitive Strengths & Weaknesses
7.6 United Laboratory
7.6.1 United Laboratory Details
7.6.2 United Laboratory Major Business
7.6.3 United Laboratory Insulin API Product and Services
7.6.4 United Laboratory Insulin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 United Laboratory Recent Developments/Updates
7.6.6 United Laboratory Competitive Strengths & Weaknesses
7.7 Biocon
7.7.1 Biocon Details
7.7.2 Biocon Major Business
7.7.3 Biocon Insulin API Product and Services
7.7.4 Biocon Insulin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Biocon Recent Developments/Updates
7.7.6 Biocon Competitive Strengths & Weaknesses
7.8 Amphastar
7.8.1 Amphastar Details
7.8.2 Amphastar Major Business
7.8.3 Amphastar Insulin API Product and Services
7.8.4 Amphastar Insulin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Amphastar Recent Developments/Updates
7.8.6 Amphastar Competitive Strengths & Weaknesses
7.9 Wockhardt
7.9.1 Wockhardt Details
7.9.2 Wockhardt Major Business
7.9.3 Wockhardt Insulin API Product and Services
7.9.4 Wockhardt Insulin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Wockhardt Recent Developments/Updates
7.9.6 Wockhardt Competitive Strengths & Weaknesses
7.10 Julphar Diabetes
7.10.1 Julphar Diabetes Details
7.10.2 Julphar Diabetes Major Business
7.10.3 Julphar Diabetes Insulin API Product and Services
7.10.4 Julphar Diabetes Insulin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Julphar Diabetes Recent Developments/Updates
7.10.6 Julphar Diabetes Competitive Strengths & Weaknesses
7.11 Torrent Pharma
7.11.1 Torrent Pharma Details
7.11.2 Torrent Pharma Major Business
7.11.3 Torrent Pharma Insulin API Product and Services
7.11.4 Torrent Pharma Insulin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Torrent Pharma Recent Developments/Updates
7.11.6 Torrent Pharma Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Insulin API Industry Chain
8.2 Insulin API Upstream Analysis
8.2.1 Insulin API Core Raw Materials
8.2.2 Main Manufacturers of Insulin API Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Insulin API Production Mode
8.6 Insulin API Procurement Model
8.7 Insulin API Industry Sales Model and Sales Channels
8.7.1 Insulin API Sales Model
8.7.2 Insulin API Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Insulin API Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Insulin API Production Value by Region (2019-2024) & (USD Million)
Table 3. World Insulin API Production Value by Region (2025-2030) & (USD Million)
Table 4. World Insulin API Production Value Market Share by Region (2019-2024)
Table 5. World Insulin API Production Value Market Share by Region (2025-2030)
Table 6. World Insulin API Production by Region (2019-2024) & (K Units)
Table 7. World Insulin API Production by Region (2025-2030) & (K Units)
Table 8. World Insulin API Production Market Share by Region (2019-2024)
Table 9. World Insulin API Production Market Share by Region (2025-2030)
Table 10. World Insulin API Average Price by Region (2019-2024) & (USD/Unit)
Table 11. World Insulin API Average Price by Region (2025-2030) & (USD/Unit)
Table 12. Insulin API Major Market Trends
Table 13. World Insulin API Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Insulin API Consumption by Region (2019-2024) & (K Units)
Table 15. World Insulin API Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Insulin API Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Insulin API Producers in 2023
Table 18. World Insulin API Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Insulin API Producers in 2023
Table 20. World Insulin API Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 21. Global Insulin API Company Evaluation Quadrant
Table 22. World Insulin API Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Insulin API Production Site of Key Manufacturer
Table 24. Insulin API Market: Company Product Type Footprint
Table 25. Insulin API Market: Company Product Application Footprint
Table 26. Insulin API Competitive Factors
Table 27. Insulin API New Entrant and Capacity Expansion Plans
Table 28. Insulin API Mergers & Acquisitions Activity
Table 29. United States VS China Insulin API Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Insulin API Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Insulin API Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Insulin API Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Insulin API Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Insulin API Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Insulin API Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Insulin API Production Market Share (2019-2024)
Table 37. China Based Insulin API Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Insulin API Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Insulin API Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Insulin API Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Insulin API Production Market Share (2019-2024)
Table 42. Rest of World Based Insulin API Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Insulin API Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Insulin API Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Insulin API Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Insulin API Production Market Share (2019-2024)
Table 47. World Insulin API Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Insulin API Production by Type (2019-2024) & (K Units)
Table 49. World Insulin API Production by Type (2025-2030) & (K Units)
Table 50. World Insulin API Production Value by Type (2019-2024) & (USD Million)
Table 51. World Insulin API Production Value by Type (2025-2030) & (USD Million)
Table 52. World Insulin API Average Price by Type (2019-2024) & (USD/Unit)
Table 53. World Insulin API Average Price by Type (2025-2030) & (USD/Unit)
Table 54. World Insulin API Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Insulin API Production by Application (2019-2024) & (K Units)
Table 56. World Insulin API Production by Application (2025-2030) & (K Units)
Table 57. World Insulin API Production Value by Application (2019-2024) & (USD Million)
Table 58. World Insulin API Production Value by Application (2025-2030) & (USD Million)
Table 59. World Insulin API Average Price by Application (2019-2024) & (USD/Unit)
Table 60. World Insulin API Average Price by Application (2025-2030) & (USD/Unit)
Table 61. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 62. Novo Nordisk Major Business
Table 63. Novo Nordisk Insulin API Product and Services
Table 64. Novo Nordisk Insulin API Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Novo Nordisk Recent Developments/Updates
Table 66. Novo Nordisk Competitive Strengths & Weaknesses
Table 67. Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
Table 68. Sanofi-Aventis Major Business
Table 69. Sanofi-Aventis Insulin API Product and Services
Table 70. Sanofi-Aventis Insulin API Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Sanofi-Aventis Recent Developments/Updates
Table 72. Sanofi-Aventis Competitive Strengths & Weaknesses
Table 73. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 74. Eli Lilly Major Business
Table 75. Eli Lilly Insulin API Product and Services
Table 76. Eli Lilly Insulin API Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Eli Lilly Recent Developments/Updates
Table 78. Eli Lilly Competitive Strengths & Weaknesses
Table 79. Tonghua Dongbao Basic Information, Manufacturing Base and Competitors
Table 80. Tonghua Dongbao Major Business
Table 81. Tonghua Dongbao Insulin API Product and Services
Table 82. Tonghua Dongbao Insulin API Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Tonghua Dongbao Recent Developments/Updates
Table 84. Tonghua Dongbao Competitive Strengths & Weaknesses
Table 85. Ganlee Basic Information, Manufacturing Base and Competitors
Table 86. Ganlee Major Business
Table 87. Ganlee Insulin API Product and Services
Table 88. Ganlee Insulin API Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Ganlee Recent Developments/Updates
Table 90. Ganlee Competitive Strengths & Weaknesses
Table 91. United Laboratory Basic Information, Manufacturing Base and Competitors
Table 92. United Laboratory Major Business
Table 93. United Laboratory Insulin API Product and Services
Table 94. United Laboratory Insulin API Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. United Laboratory Recent Developments/Updates
Table 96. United Laboratory Competitive Strengths & Weaknesses
Table 97. Biocon Basic Information, Manufacturing Base and Competitors
Table 98. Biocon Major Business
Table 99. Biocon Insulin API Product and Services
Table 100. Biocon Insulin API Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Biocon Recent Developments/Updates
Table 102. Biocon Competitive Strengths & Weaknesses
Table 103. Amphastar Basic Information, Manufacturing Base and Competitors
Table 104. Amphastar Major Business
Table 105. Amphastar Insulin API Product and Services
Table 106. Amphastar Insulin API Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Amphastar Recent Developments/Updates
Table 108. Amphastar Competitive Strengths & Weaknesses
Table 109. Wockhardt Basic Information, Manufacturing Base and Competitors
Table 110. Wockhardt Major Business
Table 111. Wockhardt Insulin API Product and Services
Table 112. Wockhardt Insulin API Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Wockhardt Recent Developments/Updates
Table 114. Wockhardt Competitive Strengths & Weaknesses
Table 115. Julphar Diabetes Basic Information, Manufacturing Base and Competitors
Table 116. Julphar Diabetes Major Business
Table 117. Julphar Diabetes Insulin API Product and Services
Table 118. Julphar Diabetes Insulin API Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Julphar Diabetes Recent Developments/Updates
Table 120. Torrent Pharma Basic Information, Manufacturing Base and Competitors
Table 121. Torrent Pharma Major Business
Table 122. Torrent Pharma Insulin API Product and Services
Table 123. Torrent Pharma Insulin API Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 124. Global Key Players of Insulin API Upstream (Raw Materials)
Table 125. Insulin API Typical Customers
Table 126. Insulin API Typical Distributors
List of Figure
Figure 1. Insulin API Picture
Figure 2. World Insulin API Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Insulin API Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Insulin API Production (2019-2030) & (K Units)
Figure 5. World Insulin API Average Price (2019-2030) & (USD/Unit)
Figure 6. World Insulin API Production Value Market Share by Region (2019-2030)
Figure 7. World Insulin API Production Market Share by Region (2019-2030)
Figure 8. North America Insulin API Production (2019-2030) & (K Units)
Figure 9. Europe Insulin API Production (2019-2030) & (K Units)
Figure 10. China Insulin API Production (2019-2030) & (K Units)
Figure 11. Japan Insulin API Production (2019-2030) & (K Units)
Figure 12. Mid East & Africa Insulin API Production (2019-2030) & (K Units)
Figure 13. India Insulin API Production (2019-2030) & (K Units)
Figure 14. Insulin API Market Drivers
Figure 15. Factors Affecting Demand
Figure 16. World Insulin API Consumption (2019-2030) & (K Units)
Figure 17. World Insulin API Consumption Market Share by Region (2019-2030)
Figure 18. United States Insulin API Consumption (2019-2030) & (K Units)
Figure 19. China Insulin API Consumption (2019-2030) & (K Units)
Figure 20. Europe Insulin API Consumption (2019-2030) & (K Units)
Figure 21. Japan Insulin API Consumption (2019-2030) & (K Units)
Figure 22. South Korea Insulin API Consumption (2019-2030) & (K Units)
Figure 23. ASEAN Insulin API Consumption (2019-2030) & (K Units)
Figure 24. India Insulin API Consumption (2019-2030) & (K Units)
Figure 25. Producer Shipments of Insulin API by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 26. Global Four-firm Concentration Ratios (CR4) for Insulin API Markets in 2023
Figure 27. Global Four-firm Concentration Ratios (CR8) for Insulin API Markets in 2023
Figure 28. United States VS China: Insulin API Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States VS China: Insulin API Production Market Share Comparison (2019 & 2023 & 2030)
Figure 30. United States VS China: Insulin API Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 31. United States Based Manufacturers Insulin API Production Market Share 2023
Figure 32. China Based Manufacturers Insulin API Production Market Share 2023
Figure 33. Rest of World Based Manufacturers Insulin API Production Market Share 2023
Figure 34. World Insulin API Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 35. World Insulin API Production Value Market Share by Type in 2023
Figure 36. Regular Human Insulin
Figure 37. Insulin Analogue
Figure 38. World Insulin API Production Market Share by Type (2019-2030)
Figure 39. World Insulin API Production Value Market Share by Type (2019-2030)
Figure 40. World Insulin API Average Price by Type (2019-2030) & (USD/Unit)
Figure 41. World Insulin API Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 42. World Insulin API Production Value Market Share by Application in 2023
Figure 43. Fast-Acting
Figure 44. Premix
Figure 45. Long-Acting
Figure 46. World Insulin API Production Market Share by Application (2019-2030)
Figure 47. World Insulin API Production Value Market Share by Application (2019-2030)
Figure 48. World Insulin API Average Price by Application (2019-2030) & (USD/Unit)
Figure 49. Insulin API Industry Chain
Figure 50. Insulin API Procurement Model
Figure 51. Insulin API Sales Model
Figure 52. Insulin API Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Novo Nordisk
Sanofi-Aventis
Eli Lilly
Tonghua Dongbao
Ganlee
United Laboratory
Biocon
Amphastar
Wockhardt
Julphar Diabetes
Torrent Pharma
btl

Related Reports

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Insulin API Supply, Demand and Key Producers, 2024-2030

Global Insulin API Supply, Demand and Key Producers, 2024-2030

Page: 131

Published Date: 18 Feb 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Insulin API market size is expected to reach $ 2175.5 million by 2030, rising at a market growth of 2.8% CAGR during the forecast period (2024-2030).

The major players in global Insulin API market include Novo Nordisk, Sanofi-Aventis, etc. The top 2 players occupy over 65% shares of the global market. North America and Europe are main markets, they occupy about 70% of the global market. Insulin Analogue is the main market, and occupies about 90% of the global market. Long-Acting is the main type, with a share over 40%.

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.

In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin. Basing on the trend of China and Chinese insulin industry, this report researches the market of human insulin and insulin analogue in China.

In this report, the statistics of insulin industry is based on Insulin API, the physical features of insulin API is Freeze-dried powder. The weight unite of insulin API weight is Kg in this report.

This report studies the global Insulin API production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Insulin API, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Insulin API that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Insulin API total production and demand, 2019-2030, (K Units)
Global Insulin API total production value, 2019-2030, (USD Million)
Global Insulin API production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Insulin API consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Insulin API domestic production, consumption, key domestic manufacturers and share
Global Insulin API production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Insulin API production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Insulin API production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Insulin API market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Sanofi-Aventis, Eli Lilly, Tonghua Dongbao, Ganlee, United Laboratory, Biocon, Amphastar and Wockhardt, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Insulin API market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Insulin API Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Insulin API Market, Segmentation by Type
Regular Human Insulin
Insulin Analogue

Global Insulin API Market, Segmentation by Application
Fast-Acting
Premix
Long-Acting

Companies Profiled:
Novo Nordisk
Sanofi-Aventis
Eli Lilly
Tonghua Dongbao
Ganlee
United Laboratory
Biocon
Amphastar
Wockhardt
Julphar Diabetes
Torrent Pharma

Key Questions Answered
1. How big is the global Insulin API market?
2. What is the demand of the global Insulin API market?
3. What is the year over year growth of the global Insulin API market?
4. What is the production and production value of the global Insulin API market?
5. Who are the key producers in the global Insulin API market?
btl

Table of Contents

1 Supply Summary
1.1 Insulin API Introduction
1.2 World Insulin API Supply & Forecast
1.2.1 World Insulin API Production Value (2019 & 2023 & 2030)
1.2.2 World Insulin API Production (2019-2030)
1.2.3 World Insulin API Pricing Trends (2019-2030)
1.3 World Insulin API Production by Region (Based on Production Site)
1.3.1 World Insulin API Production Value by Region (2019-2030)
1.3.2 World Insulin API Production by Region (2019-2030)
1.3.3 World Insulin API Average Price by Region (2019-2030)
1.3.4 North America Insulin API Production (2019-2030)
1.3.5 Europe Insulin API Production (2019-2030)
1.3.6 China Insulin API Production (2019-2030)
1.3.7 Japan Insulin API Production (2019-2030)
1.3.8 Mid East & Africa Insulin API Production (2019-2030)
1.3.9 India Insulin API Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Insulin API Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Insulin API Major Market Trends

2 Demand Summary
2.1 World Insulin API Demand (2019-2030)
2.2 World Insulin API Consumption by Region
2.2.1 World Insulin API Consumption by Region (2019-2024)
2.2.2 World Insulin API Consumption Forecast by Region (2025-2030)
2.3 United States Insulin API Consumption (2019-2030)
2.4 China Insulin API Consumption (2019-2030)
2.5 Europe Insulin API Consumption (2019-2030)
2.6 Japan Insulin API Consumption (2019-2030)
2.7 South Korea Insulin API Consumption (2019-2030)
2.8 ASEAN Insulin API Consumption (2019-2030)
2.9 India Insulin API Consumption (2019-2030)

3 World Insulin API Manufacturers Competitive Analysis
3.1 World Insulin API Production Value by Manufacturer (2019-2024)
3.2 World Insulin API Production by Manufacturer (2019-2024)
3.3 World Insulin API Average Price by Manufacturer (2019-2024)
3.4 Insulin API Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Insulin API Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Insulin API in 2023
3.5.3 Global Concentration Ratios (CR8) for Insulin API in 2023
3.6 Insulin API Market: Overall Company Footprint Analysis
3.6.1 Insulin API Market: Region Footprint
3.6.2 Insulin API Market: Company Product Type Footprint
3.6.3 Insulin API Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Insulin API Production Value Comparison
4.1.1 United States VS China: Insulin API Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Insulin API Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Insulin API Production Comparison
4.2.1 United States VS China: Insulin API Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Insulin API Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Insulin API Consumption Comparison
4.3.1 United States VS China: Insulin API Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Insulin API Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Insulin API Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Insulin API Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Insulin API Production Value (2019-2024)
4.4.3 United States Based Manufacturers Insulin API Production (2019-2024)
4.5 China Based Insulin API Manufacturers and Market Share
4.5.1 China Based Insulin API Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Insulin API Production Value (2019-2024)
4.5.3 China Based Manufacturers Insulin API Production (2019-2024)
4.6 Rest of World Based Insulin API Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Insulin API Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Insulin API Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Insulin API Production (2019-2024)

5 Market Analysis by Type
5.1 World Insulin API Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Regular Human Insulin
5.2.2 Insulin Analogue
5.3 Market Segment by Type
5.3.1 World Insulin API Production by Type (2019-2030)
5.3.2 World Insulin API Production Value by Type (2019-2030)
5.3.3 World Insulin API Average Price by Type (2019-2030)

6 Market Analysis by Application
6.1 World Insulin API Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Fast-Acting
6.2.2 Premix
6.2.3 Long-Acting
6.3 Market Segment by Application
6.3.1 World Insulin API Production by Application (2019-2030)
6.3.2 World Insulin API Production Value by Application (2019-2030)
6.3.3 World Insulin API Average Price by Application (2019-2030)

7 Company Profiles
7.1 Novo Nordisk
7.1.1 Novo Nordisk Details
7.1.2 Novo Nordisk Major Business
7.1.3 Novo Nordisk Insulin API Product and Services
7.1.4 Novo Nordisk Insulin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Novo Nordisk Recent Developments/Updates
7.1.6 Novo Nordisk Competitive Strengths & Weaknesses
7.2 Sanofi-Aventis
7.2.1 Sanofi-Aventis Details
7.2.2 Sanofi-Aventis Major Business
7.2.3 Sanofi-Aventis Insulin API Product and Services
7.2.4 Sanofi-Aventis Insulin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Sanofi-Aventis Recent Developments/Updates
7.2.6 Sanofi-Aventis Competitive Strengths & Weaknesses
7.3 Eli Lilly
7.3.1 Eli Lilly Details
7.3.2 Eli Lilly Major Business
7.3.3 Eli Lilly Insulin API Product and Services
7.3.4 Eli Lilly Insulin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Eli Lilly Recent Developments/Updates
7.3.6 Eli Lilly Competitive Strengths & Weaknesses
7.4 Tonghua Dongbao
7.4.1 Tonghua Dongbao Details
7.4.2 Tonghua Dongbao Major Business
7.4.3 Tonghua Dongbao Insulin API Product and Services
7.4.4 Tonghua Dongbao Insulin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Tonghua Dongbao Recent Developments/Updates
7.4.6 Tonghua Dongbao Competitive Strengths & Weaknesses
7.5 Ganlee
7.5.1 Ganlee Details
7.5.2 Ganlee Major Business
7.5.3 Ganlee Insulin API Product and Services
7.5.4 Ganlee Insulin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Ganlee Recent Developments/Updates
7.5.6 Ganlee Competitive Strengths & Weaknesses
7.6 United Laboratory
7.6.1 United Laboratory Details
7.6.2 United Laboratory Major Business
7.6.3 United Laboratory Insulin API Product and Services
7.6.4 United Laboratory Insulin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 United Laboratory Recent Developments/Updates
7.6.6 United Laboratory Competitive Strengths & Weaknesses
7.7 Biocon
7.7.1 Biocon Details
7.7.2 Biocon Major Business
7.7.3 Biocon Insulin API Product and Services
7.7.4 Biocon Insulin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Biocon Recent Developments/Updates
7.7.6 Biocon Competitive Strengths & Weaknesses
7.8 Amphastar
7.8.1 Amphastar Details
7.8.2 Amphastar Major Business
7.8.3 Amphastar Insulin API Product and Services
7.8.4 Amphastar Insulin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Amphastar Recent Developments/Updates
7.8.6 Amphastar Competitive Strengths & Weaknesses
7.9 Wockhardt
7.9.1 Wockhardt Details
7.9.2 Wockhardt Major Business
7.9.3 Wockhardt Insulin API Product and Services
7.9.4 Wockhardt Insulin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Wockhardt Recent Developments/Updates
7.9.6 Wockhardt Competitive Strengths & Weaknesses
7.10 Julphar Diabetes
7.10.1 Julphar Diabetes Details
7.10.2 Julphar Diabetes Major Business
7.10.3 Julphar Diabetes Insulin API Product and Services
7.10.4 Julphar Diabetes Insulin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Julphar Diabetes Recent Developments/Updates
7.10.6 Julphar Diabetes Competitive Strengths & Weaknesses
7.11 Torrent Pharma
7.11.1 Torrent Pharma Details
7.11.2 Torrent Pharma Major Business
7.11.3 Torrent Pharma Insulin API Product and Services
7.11.4 Torrent Pharma Insulin API Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.11.5 Torrent Pharma Recent Developments/Updates
7.11.6 Torrent Pharma Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Insulin API Industry Chain
8.2 Insulin API Upstream Analysis
8.2.1 Insulin API Core Raw Materials
8.2.2 Main Manufacturers of Insulin API Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Insulin API Production Mode
8.6 Insulin API Procurement Model
8.7 Insulin API Industry Sales Model and Sales Channels
8.7.1 Insulin API Sales Model
8.7.2 Insulin API Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Insulin API Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Insulin API Production Value by Region (2019-2024) & (USD Million)
Table 3. World Insulin API Production Value by Region (2025-2030) & (USD Million)
Table 4. World Insulin API Production Value Market Share by Region (2019-2024)
Table 5. World Insulin API Production Value Market Share by Region (2025-2030)
Table 6. World Insulin API Production by Region (2019-2024) & (K Units)
Table 7. World Insulin API Production by Region (2025-2030) & (K Units)
Table 8. World Insulin API Production Market Share by Region (2019-2024)
Table 9. World Insulin API Production Market Share by Region (2025-2030)
Table 10. World Insulin API Average Price by Region (2019-2024) & (USD/Unit)
Table 11. World Insulin API Average Price by Region (2025-2030) & (USD/Unit)
Table 12. Insulin API Major Market Trends
Table 13. World Insulin API Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Insulin API Consumption by Region (2019-2024) & (K Units)
Table 15. World Insulin API Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Insulin API Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Insulin API Producers in 2023
Table 18. World Insulin API Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Insulin API Producers in 2023
Table 20. World Insulin API Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 21. Global Insulin API Company Evaluation Quadrant
Table 22. World Insulin API Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Insulin API Production Site of Key Manufacturer
Table 24. Insulin API Market: Company Product Type Footprint
Table 25. Insulin API Market: Company Product Application Footprint
Table 26. Insulin API Competitive Factors
Table 27. Insulin API New Entrant and Capacity Expansion Plans
Table 28. Insulin API Mergers & Acquisitions Activity
Table 29. United States VS China Insulin API Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Insulin API Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Insulin API Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Insulin API Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Insulin API Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Insulin API Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Insulin API Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Insulin API Production Market Share (2019-2024)
Table 37. China Based Insulin API Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Insulin API Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Insulin API Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Insulin API Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Insulin API Production Market Share (2019-2024)
Table 42. Rest of World Based Insulin API Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Insulin API Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Insulin API Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Insulin API Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Insulin API Production Market Share (2019-2024)
Table 47. World Insulin API Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Insulin API Production by Type (2019-2024) & (K Units)
Table 49. World Insulin API Production by Type (2025-2030) & (K Units)
Table 50. World Insulin API Production Value by Type (2019-2024) & (USD Million)
Table 51. World Insulin API Production Value by Type (2025-2030) & (USD Million)
Table 52. World Insulin API Average Price by Type (2019-2024) & (USD/Unit)
Table 53. World Insulin API Average Price by Type (2025-2030) & (USD/Unit)
Table 54. World Insulin API Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Insulin API Production by Application (2019-2024) & (K Units)
Table 56. World Insulin API Production by Application (2025-2030) & (K Units)
Table 57. World Insulin API Production Value by Application (2019-2024) & (USD Million)
Table 58. World Insulin API Production Value by Application (2025-2030) & (USD Million)
Table 59. World Insulin API Average Price by Application (2019-2024) & (USD/Unit)
Table 60. World Insulin API Average Price by Application (2025-2030) & (USD/Unit)
Table 61. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 62. Novo Nordisk Major Business
Table 63. Novo Nordisk Insulin API Product and Services
Table 64. Novo Nordisk Insulin API Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Novo Nordisk Recent Developments/Updates
Table 66. Novo Nordisk Competitive Strengths & Weaknesses
Table 67. Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
Table 68. Sanofi-Aventis Major Business
Table 69. Sanofi-Aventis Insulin API Product and Services
Table 70. Sanofi-Aventis Insulin API Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Sanofi-Aventis Recent Developments/Updates
Table 72. Sanofi-Aventis Competitive Strengths & Weaknesses
Table 73. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 74. Eli Lilly Major Business
Table 75. Eli Lilly Insulin API Product and Services
Table 76. Eli Lilly Insulin API Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Eli Lilly Recent Developments/Updates
Table 78. Eli Lilly Competitive Strengths & Weaknesses
Table 79. Tonghua Dongbao Basic Information, Manufacturing Base and Competitors
Table 80. Tonghua Dongbao Major Business
Table 81. Tonghua Dongbao Insulin API Product and Services
Table 82. Tonghua Dongbao Insulin API Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Tonghua Dongbao Recent Developments/Updates
Table 84. Tonghua Dongbao Competitive Strengths & Weaknesses
Table 85. Ganlee Basic Information, Manufacturing Base and Competitors
Table 86. Ganlee Major Business
Table 87. Ganlee Insulin API Product and Services
Table 88. Ganlee Insulin API Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Ganlee Recent Developments/Updates
Table 90. Ganlee Competitive Strengths & Weaknesses
Table 91. United Laboratory Basic Information, Manufacturing Base and Competitors
Table 92. United Laboratory Major Business
Table 93. United Laboratory Insulin API Product and Services
Table 94. United Laboratory Insulin API Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. United Laboratory Recent Developments/Updates
Table 96. United Laboratory Competitive Strengths & Weaknesses
Table 97. Biocon Basic Information, Manufacturing Base and Competitors
Table 98. Biocon Major Business
Table 99. Biocon Insulin API Product and Services
Table 100. Biocon Insulin API Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Biocon Recent Developments/Updates
Table 102. Biocon Competitive Strengths & Weaknesses
Table 103. Amphastar Basic Information, Manufacturing Base and Competitors
Table 104. Amphastar Major Business
Table 105. Amphastar Insulin API Product and Services
Table 106. Amphastar Insulin API Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Amphastar Recent Developments/Updates
Table 108. Amphastar Competitive Strengths & Weaknesses
Table 109. Wockhardt Basic Information, Manufacturing Base and Competitors
Table 110. Wockhardt Major Business
Table 111. Wockhardt Insulin API Product and Services
Table 112. Wockhardt Insulin API Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Wockhardt Recent Developments/Updates
Table 114. Wockhardt Competitive Strengths & Weaknesses
Table 115. Julphar Diabetes Basic Information, Manufacturing Base and Competitors
Table 116. Julphar Diabetes Major Business
Table 117. Julphar Diabetes Insulin API Product and Services
Table 118. Julphar Diabetes Insulin API Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 119. Julphar Diabetes Recent Developments/Updates
Table 120. Torrent Pharma Basic Information, Manufacturing Base and Competitors
Table 121. Torrent Pharma Major Business
Table 122. Torrent Pharma Insulin API Product and Services
Table 123. Torrent Pharma Insulin API Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 124. Global Key Players of Insulin API Upstream (Raw Materials)
Table 125. Insulin API Typical Customers
Table 126. Insulin API Typical Distributors
List of Figure
Figure 1. Insulin API Picture
Figure 2. World Insulin API Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Insulin API Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Insulin API Production (2019-2030) & (K Units)
Figure 5. World Insulin API Average Price (2019-2030) & (USD/Unit)
Figure 6. World Insulin API Production Value Market Share by Region (2019-2030)
Figure 7. World Insulin API Production Market Share by Region (2019-2030)
Figure 8. North America Insulin API Production (2019-2030) & (K Units)
Figure 9. Europe Insulin API Production (2019-2030) & (K Units)
Figure 10. China Insulin API Production (2019-2030) & (K Units)
Figure 11. Japan Insulin API Production (2019-2030) & (K Units)
Figure 12. Mid East & Africa Insulin API Production (2019-2030) & (K Units)
Figure 13. India Insulin API Production (2019-2030) & (K Units)
Figure 14. Insulin API Market Drivers
Figure 15. Factors Affecting Demand
Figure 16. World Insulin API Consumption (2019-2030) & (K Units)
Figure 17. World Insulin API Consumption Market Share by Region (2019-2030)
Figure 18. United States Insulin API Consumption (2019-2030) & (K Units)
Figure 19. China Insulin API Consumption (2019-2030) & (K Units)
Figure 20. Europe Insulin API Consumption (2019-2030) & (K Units)
Figure 21. Japan Insulin API Consumption (2019-2030) & (K Units)
Figure 22. South Korea Insulin API Consumption (2019-2030) & (K Units)
Figure 23. ASEAN Insulin API Consumption (2019-2030) & (K Units)
Figure 24. India Insulin API Consumption (2019-2030) & (K Units)
Figure 25. Producer Shipments of Insulin API by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 26. Global Four-firm Concentration Ratios (CR4) for Insulin API Markets in 2023
Figure 27. Global Four-firm Concentration Ratios (CR8) for Insulin API Markets in 2023
Figure 28. United States VS China: Insulin API Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States VS China: Insulin API Production Market Share Comparison (2019 & 2023 & 2030)
Figure 30. United States VS China: Insulin API Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 31. United States Based Manufacturers Insulin API Production Market Share 2023
Figure 32. China Based Manufacturers Insulin API Production Market Share 2023
Figure 33. Rest of World Based Manufacturers Insulin API Production Market Share 2023
Figure 34. World Insulin API Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 35. World Insulin API Production Value Market Share by Type in 2023
Figure 36. Regular Human Insulin
Figure 37. Insulin Analogue
Figure 38. World Insulin API Production Market Share by Type (2019-2030)
Figure 39. World Insulin API Production Value Market Share by Type (2019-2030)
Figure 40. World Insulin API Average Price by Type (2019-2030) & (USD/Unit)
Figure 41. World Insulin API Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 42. World Insulin API Production Value Market Share by Application in 2023
Figure 43. Fast-Acting
Figure 44. Premix
Figure 45. Long-Acting
Figure 46. World Insulin API Production Market Share by Application (2019-2030)
Figure 47. World Insulin API Production Value Market Share by Application (2019-2030)
Figure 48. World Insulin API Average Price by Application (2019-2030) & (USD/Unit)
Figure 49. Insulin API Industry Chain
Figure 50. Insulin API Procurement Model
Figure 51. Insulin API Sales Model
Figure 52. Insulin API Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Novo Nordisk
Sanofi-Aventis
Eli Lilly
Tonghua Dongbao
Ganlee
United Laboratory
Biocon
Amphastar
Wockhardt
Julphar Diabetes
Torrent Pharma
btl

Related Reports

jiaGou

Add To Cart

gouMai

Buy Now